SYNTHESIS OF 1α,25-DIHYDROXY-2β-(3-HYDROXYPROPOXY)VITAMIN D3 (ELDECALCITOL) AND RELATED COMPOUNDS BY THE TROST CONVERGENT METHODOLOGY

被引：8

作者：

Kubodera, Noboru ^{[1
]}

Hatakeyama, Susumi ^{[2
]}

机构：

[1] Chugai Pharmaceut Co Ltd, Chuo Ku, Tokyo 1038324, Japan

[2] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 8528521, Japan

来源：

HETEROCYCLES | 2009年 / 79卷

关键词：

Active Vitamin D-3 Analog; Calcitriol; 1; alpha; 25-Dihydroxy-2 beta-(3-hydroxypropoxy)vitamin D-3; Eldecalcitol; Trost Convergent Methodology; VITAMIN-D ANALOGS; BONE-MINERAL LOSS; PARATHYROID-HORMONE SECRETION; OVARIECTOMIZED RATS; 1-ALPHA; 25-DIHYDROXYVITAMIN D-3; OSTEOPOROTIC PATIENTS; BIOLOGICAL EVALUATION; POTENT SUPPRESSOR; D-RIBONOLACTONE; D METABOLITES;

D O I：

10.3987/REV-08-SR(D)3

中图分类号：

O62 [有机化学];

学科分类号：

070303 ; 081704 ;

摘要：

Using Trost convergent methodology, the synthesis of 1 alpha,25-dihydroxy-2 beta-(3-hydroxypropoxy)vitamin D-3 (eldecalcitol) for the improved and industrial scale production and related putative metabolites of eldecalcitol is summarized. In addition, A-ring diastereomers at the 1- and 3-positions of eldecalcitol are described. The synthesis centers on a key palladium-catalyzed alkylative cyclization and coupling of ene-ynes that constitute the A-ring fragment to bromomethylenes comprising the C/D-ring fragment which affords the requisite triene framework of vitamin D-3 analogs.

引用

页码：145 / 162

页数：18

共 50 条

[31] Synthesis of novel 1α,25-dihydroxy-19-norvitamin D3 with an amide conjugate
Suhara, Y
Ono, K
Yoshida, A
Fujishima, T
Saito, N
Honzawa, S
Kishimoto, S
Sugiura, T
Waku, K
Takayama, H
Kittaka, A
HETEROCYCLES, 2004, 62 : 423 - 436
[32] Identification of 7-dehydrocholesterol, vitamin D3, 25(OH)-vitamin D3 and 1,25(OH)2-vitamin D3 in Solanum glaucophyllum cultures grown in absence of light
Curino, A
Skliar, M
Boland, R
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 1998, 1425 (03): : 485 - 492
[33] History of the development of new vitamin D analogs:: studies on 22-oxacalcitriol (OCT) and 2β-(3-hydroxypropoxy)calcitriol (ED-71)
Nishii, Y
Okano, T
STEROIDS, 2001, 66 (3-5) : 137 - 146
[34] 1α,25-dihydroxy-16-ene-23-yne-vitamin D3 and 1α,25-dihydroxy-16-ene-23-yne-20-epi-vitamin D3:: Analogs of 1α,25-dihydroxyvitamin D3 that resist metabolism through the C-24 oxidation pathway are metabolized through the C-3 epimerization pathway
Reddy, GS
Rao, DS
Siu-Caldera, ML
Astecker, N
Weiskopf, A
Vouros, P
Sasso, GJ
Manchand, PS
Uskokovic, MR
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2000, 383 (02) : 197 - 205
[35] Conversion of vitamin D3 to 1α,25-dihydroxyvitamin D3 in human skin equivalents
Lehmann, B
Rudolph, T
Pietzsch, J
Meurer, M
EXPERIMENTAL DERMATOLOGY, 2000, 9 (02) : 97 - 103
[36] Human keratinocyte line HaCaT metabolizes 1α-hydroxyvitamin D3 and vitamin D3 to 1α,25-dihydroxyvitamin D3 (calcitriol)
Lehmann, B
Pietzsch, J
Kampf, A
Meurer, M
JOURNAL OF DERMATOLOGICAL SCIENCE, 1998, 18 (02) : 118 - 127
[37] Update on biological actions of 1α,25(OH)2-vitamin D3 (rapid effects) and 24R,25(OH)2-vitamin D3
Norman, AW
Okamura, WH
Bishop, JE
Henry, HL
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2002, 197 (1-2) : 1 - 13
[38] Effect of 1α,25-dihydroxy vitamin D3 and vitamin E on insulin-induced glucose uptake in rat adipocytes
Huang, YN
Ishizuka, T
Miura, A
Kajita, K
Ishizawa, M
Kimura, M
Yamamoto, Y
Kawai, Y
Morita, H
Uno, Y
Yasuda, K
DIABETES RESEARCH AND CLINICAL PRACTICE, 2002, 55 (03) : 175 - 183
[39] Effect of 25-hydroxyl group orientation on biological activity and binding to the 1α,25-dihydroxy vitamin D3 receptor
Collins, ED
Bishop, JE
Bula, CM
Acevedo, A
Okamura, WH
Norman, AW
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2005, 94 (04): : 279 - 288
[40] Cytoskeletal reorganisation, 1α,25-dihydroxy vitamin D3 and human MG63 osteoblast maturation
Mansell, Jason Peter
Farrar, David
Jones, Scott
Nowghani, Maryam
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2009, 305 (1-2) : 38 - 46

← 1 2 3 4 5 →